Treatment of membranous nephropathy with crescent nephritis by rituximab: A case report

被引：0
作者：
Zhang, Fan [1 ,2 ]
Yang, Yiya [1 ,2 ]
Chen, Yinyin [1 ,2 ]
Chen, Ying [1 ,2 ]
Yin, Wei [1 ,2 ]
Liang, Yumei [1 ,2 ]
Luo, Xun [1 ,2 ]
机构：
[1] Hunan Normal Univ, Hunan Prov Peoples Hosp, Dept Nephrol, 61 West Jiefang Rd, Changsha 410000, Hunan, Peoples R China
[2] Hunan Normal Univ, Hunan Prov Peoples Hosp, Lab Kidney Dis, 61 West Jiefang Rd, Changsha 410000, Hunan, Peoples R China
来源：
MEDICINE | 2022年 / 101卷 / 37期
关键词：
antiphospholipaseA2 receptor antibodies; crescentic glomerulonephritis; membranous nephropathy; RECEPTOR; ANTIBODY; GLOMERULONEPHRITIS; ANTIGEN;
D O I：
10.1097/MD.0000000000030663
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Background: Crescent formation is rare in primary membranous nephropathy (MN). The mechanism of crescent formation is unknown and the treatments are tentative. Patient concerns: A 71-year-old woman presented with nephrotic syndrome, hematuria, and rapidly progressive kidney dysfunction. Diagnosis: Kidney biopsy was performed, and the diagnosis was MN in combination with crescentic glomerulonephritis. Circulating anti-PLA2R was detected of a high level. Interventions: The patient received rituximab besides corticosteroids. Outcomes: The patient achieved complete remission of proteinuria and recovery of kidney function. Conclusion: Our case suggests that there is a pathologic feature of MN and crescents in the absence of known immunologic factors as well as rituximab could serve as an effective cure and could be considered in serious MN conditions.
引用
收藏
页数：3
相关论文
共 13 条
[1]   Membranous glomerulonephritis with crescents [J].
Barrett, Caroline M. F. ;
Troxell, Megan L. ;
Larsen, Christopher P. ;
Houghton, Donald C. .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2014, 46 (05) :963-971
[2]   M-Type Phospholipase A(sub 2) Receptor as Target Antigen in Idiopathic Membranous Nephropathy. [J].
Beck, Laurence H., Jr. ;
Bonegio, Ramon G. B. ;
Lambeau, Gerard ;
Beck, David M. ;
Powell, David W. ;
Cummins, Timothy D. ;
Klein, Jon B. ;
Salant, David J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (01) :11-21
[3]   RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS - CLASSIFICATION, PATHOGENETIC MECHANISMS, AND THERAPY [J].
COUSER, WG .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1988, 11 (06) :449-464
[4]   Primary Membranous Nephropathy [J].
Couser, William G. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (06) :983-997
[5]   The pathogenesis of membranous nephropathy: evolution and revolution [J].
Glassock, Richard J. .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2012, 21 (03) :235-242
[6]   The Pathogenesis of Idiopathic Membranous Nephropathy: A 50-Year Odyssey [J].
Glassock, Richard J. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 56 (01) :157-167
[7]   Anti-Phospholipase A2 Receptor (Anti-PLA2R) Antibody in Diagnosis and Treatment of Idiopathic Membranous Nephropathy: A Single-Center Observational Study in China [J].
Guo, Naifeng ;
Cao, Yingjie ;
Dai, Houyong ;
Yuan, Li ;
Shi, Lan ;
Zhang, Yide .
MEDICAL SCIENCE MONITOR, 2019, 25 :9364-9368
[8]   Antiphospholipase A2 Receptor Antibody Titer and Subclass in Idiopathic Membranous Nephropathy [J].
Hofstra, Julia M. ;
Debiec, Hanna ;
Short, Colin D. ;
Pelle, Tinnothee ;
Kleta, Robert ;
Mathieson, Peter W. ;
Ronco, Pierre ;
Brenchley, Paul E. ;
Wetzels, Jack F. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (10) :1735-1743
[9]   Plasma exchange and rituximab treatments in primary membranous nephropathy combined with crescentic glomerulonephritis A case report [J].
Lu, Hui ;
Cui, Zhao ;
Zhou, Xu-jie ;
Jin, Qi-zhuang ;
Yu, Xiao-juan ;
Wang, Su-xia ;
Wang, Yu ;
Zhou, Fu-de ;
Zhao, Ming-hui .
MEDICINE, 2019, 98 (18)
[10]   Antiphospholipase 2 receptor antibody levels to predict complete spontaneous remission in primary membranous nephropathy [J].
Rodas, Lida M. ;
Matas-Garcia, Ana ;
Barros, Xoana ;
Blasco, Miguel ;
Vinas, Odette ;
Llobell, Arturo ;
Martin, Nadia ;
Quintana, Luis F. .
CLINICAL KIDNEY JOURNAL, 2019, 12 (01) :36-41
12